Fragment-based Drug Discovery Market – Global Industry Size, Trends, Growth, Analysis and Forecast 2018-2026

Global Fragment-based Drug Discovery Market was valued at US$ 503.4 Mn in 2017 expanding at a CAGR of 11.8% from 2018 to 2026

SAN JOSE, United States - December 6, 2018 /MarketersMedia/ —

Fragment-based Drug Discovery Market Expected To Exhibit Rapid Growth During The Forecast Period

The latest market report published by Credence Research, Inc. “Fragment-based Drug Discovery Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026”

Market Insights

There has been a tremendous increase in the drug discovery technologies in the recent past with assistance from functional genomics, combinational chemistry and high-throughput screening. Despite these advancements the number of new chemical entity (NCEs) entering the development phase has remained static. Fragment-based drug discovery has emerged as one of the most productive techniques of lead generation. Fragments are low molecular weight small molecules that form of part of drug molecules.

Browse the full report at

As they binds to an active site of target protein, they can be developed into highly potent and effective drug candidate. Fragment-based drug discovery technique requires less molecules as compared to high-throughput screening while offering more efficient and productive drug candidates. Growing need to curb initially drug discovery cost and time will assist the growth of fragment-based drug discovery market. Moreover, technological advancements in novel drug discovery methods will further boost the market during the forecast period.

In terms of end-users, the fragment-based drug discovery market is led by biopharmaceutical companies. Growing demand of fragment-based method by biopharmaceutical companies is driving the market. Moreover, this technique is also useful where other screening techniques have already failed. In terms of geography, North America held the largest share in the global fragment-based drug discovery market owing to high rate of drug discovery and R&D initiatives undertaken in the region. Moreover, higher acceptance of novel technologies and domicile of major biopharmaceutical giants in the region drive the market.

Asia Pacific is projected to exhibit fastest growth rate during the forecast period owing to rise in outsourcing of pharmaceutical development and growing number of contract research organization (CROs) and contract manufacturing organization (CMOs) in the region. China, India and South Korea are the manufacturing hub worldwide and high investments in the region by pharmaceutical companies further boost the growth of the region, thereby driving the fragment-based drug discovery market in Asia Pacific. The key players operating in the market include Astex Pharmaceuticals, Charles River Laboratories International, Inc., Evotec AG, Kinetic Discovery Limited, and Alveus Pharmaceuticals Pvt. Ltd. among others.

Key Market Movements:

Growing need for cost-effective and time saving drug discovery method
Technological advancement in novel drug discovery techniques
Combination of high-throughput screening and fragment-based drug discovery method for highly efficient lead generation
Growth of CROs and outsourcing of pharmaceutical development in Asia Pacific driving the market


Chapter 4. Global Fragment-based Drug Discovery Market, by Service Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Fragment Screening Technique
4.2.1. NMR Spectroscopy
4.2.2. Differential Scanning Fluorimetry (DSF)
4.2.3. X-Ray Crystallography
4.2.4. Fluorescence Polarization (FP)
4.2.5. Isothermal Titration Calorimetry (ITC)
4.2.6. Surface Plasmon Resonance (SPR)
4.2.7. Mass Spectrometry (MS)
4.2.8. Capillary Electrophoresis (CE)
4.2.9. Others
4.3. Fragment Optimization Technique

Chapter 5. Global Fragment-based Drug Discovery Market, by End-User, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Biopharmaceutical Companies
5.3. Contract Research Organization
5.4. Academic and Research Institutions

Chapter 6. Global Fragment-based Drug Discovery Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Fragment-based Drug Discovery Market Analysis, 2016 – 2026
6.1.1. North America Fragment-based Drug Discovery Market, by Service Type, 2016 - 2026 (US$ Mn)
6.1.2. North America Fragment-based Drug Discovery Market, by End-User, 2016 - 2026 (US$ Mn)
6.1.3. North America Fragment-based Drug Discovery Market, by Country, 2016 – 2026 (US$ Mn) U.S. Canada
6.2. Europe Fragment-based Drug Discovery Market Analysis, 2016 – 2026
6.2.1. Europe Fragment-based Drug Discovery Market, by Service Type, 2016 - 2026 (US$ Mn)
6.2.2. Europe Fragment-based Drug Discovery Market, by End-User, 2016 - 2026 (US$ Mn)
6.2.3. Europe Fragment-based Drug Discovery Market, by Country/Region, 2016 – 2026 (US$ Mn) ...

Chapter 7. Company Profiles
7.1. Astex Pharmaceuticals
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Alveus Pharmaceuticals Pvt. Ltd.
7.3. Beactica AB
7.4. Charles River Laboratories International, Inc.
7.5. Crown Bioscience, Inc.
7.6. Emerald BioStructures, Inc.
7.7. Evotec AG ...

Browse the full report at

Related Reports :

Osteoarthritis Treatment Market :

Central Nervous System (CNS) Biomarkers Market :

About us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research Inc
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290

Source URL:

Source: MarketersMedia

Release ID: 455861

More Press Releases

Nissan to replace rock-star chairman amid arrest scandal

Dec 17, 2018

TOKYO — Nissan's board is meeting to pick a chairman to replace Carlos Ghosn, arrested last month on charges of violating financial regulations. Monday's meeting comes amid an unfolding scandal that threatens the Japanese automaker's two-decade alliance with Renault SA of France and its global brand, as well as highlighting shoddy governance at the manufacturer of the Leaf electric car. Ghosn and another board member Greg Kelly were formally charged last week with falsifying financial reports in underreporting Ghosn's income by about 5 billion yen ($44 million) between 2011 and 2015. They were arrested Nov. 19 by Tokyo prosecutors and...

Top of mind: 'Justice' is Merriam-Webster's word of the year

Dec 17, 2018

NEW YORK — Racial justice. Obstruction of justice. Social justice. The Justice Department. Merriam-Webster has chosen "justice" as its 2018 word of the year, driven by the churning news cycle over months and months. The word follows "toxic," picked by Oxford Dictionaries, and "misinformation," plucked by Peter Sokolowski, Merriam-Webster's editor at large, told The Associated Press ahead of Monday's announcement that "justice" consistently bubbled into the top 20 or 30 lookups on the company's website, spiking at times due to specific events but also skating close to the surface for much of the year. While it's one of those...

Offset interruption of Cardi B at Rolling Loud spurs outrage

Dec 17, 2018

LOS ANGELES — Cardi B is asking the public to not bash Offset, who became the target of internet outrage after he interrupted her set at the Rolling Loud Festival in Los Angeles Saturday night and asked her to get back together with him. Cardi B on Sunday said in an Instagram video that she wishes people wouldn't bash the father of her daughter. The festival's co-founder Tariq Cherif said in a statement Sunday that the festival had nothing to do with Offset's appearance and that headliners and their teams have full control of the stage and who is allowed...

'SNL' gets fresh round of Trump wrath after Christmas skit

Dec 17, 2018

LOS ANGELES — President Donald Trump is criticizing "Saturday Night Live" on Twitter again the morning after a Christmas-themed spoof on the sketch-comedy show focused on him. Trump on Sunday called "SNL" and NBC "democratic spin machines." On Saturday night, "SNL" opened with an "It's a Wonderful Life" themed sketch that imagined a White House without Trump. Alec Baldwin returned to play the president once again. Trump has often been critical of "SNL" and Baldwin's portrayal of him, and has taken to Twitter in the past to express his frustrations, even getting into spats with Baldwin. In his tweet Sunday,...

'Spider-Verse' swings to the top; 'Mortal Engines' tanks

Dec 17, 2018

LOS ANGELES — "Spider-Man: Into the Spider-Verse" swung to the top of the domestic box office in its first weekend in theaters, proving that there is widespread audience interest in big screen animated versions of Marvel's marquee superheroes. The film led a host of newcomers that debuted to varying success on this pre-Christmas holiday weekend, including Clint Eastwood's drug smuggling drama "The Mule" and the Peter Jackson-produced epic "Mortal Engines" which bombed in North American theaters. "Into the Spider-Verse" earned an estimated $35.4 million from 3,813 theaters against a $90 million production budget according to Sony Pictures on Sunday, which...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Contact us:

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases